INTRODUCTION
Neurotoxins produced by Clostridium botulinum that target peripheral cholinergic nerve endings are the most potent biological toxins. The seven serotypes of the toxin, designated BoNT/A to G (1), selectively cleave the SNARE complex proteins and inhibit acetylcholine release. Inhibition of neuromuscular transmission leads to paralysis (2) . This action involves a cascade of cellular events including toxin binding to specific receptors (3, 4) , internalization by endocytosis, and translocation of the toxin light chain from endosomes to cytosol in a pH dependent process. The light chain metalloendoprotease of serotypes A and E cleave SNAP-25. Light chains of serotypes B, D, F and G cleave synaptobrevin II.
Serotype C light chain cleaves primarily syntaxin I, as well as SNAP-25 in some cells (5, 6) . Vesicular release of acetylcholine from motor nerve endings is an exocytic process which adds synaptic vesicle (SV) membrane to the nerve terminal membrane (7) (8) (9) (10) . This process of exocytosis is associated with compensatory endocytosis to replenish SV membrane and to maintain nerve terminal size. SV membrane retrieval from the terminal membrane may utilize clathrin coated pit (CCP) mediated endocytosis which requires phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 , 11). Increasing data indicate that the interaction of PI(4,5)P 2 with components of the endocytotic machinery is critical to CCP mediated endocytosis (12) (13) (14) (15) (16) .
In mammalian cells, PI(4,5)P 2 results from phosphatidylinositol-4-phosphate-5-kinase (PIP5K) phosphorylation of phosphatidylinositol-4-phosphate PI(4)P (17, 18) . PI(4,5)P 2 interacts with several proteins that regulate exo-endocytosis of SVs. For example, binding of PI(4,5)P 2 to synaptotagmin at concentrations of Ca 2+ typically found in the presynaptic terminal of a stimulated neuron modulates docking of SVs (19). PI(4,5)P 2 also binds to rabphilin 3 (20) and controls the formation of the SNARE complex. Other interactions that are relevant to vesicular secretion includes PI(4,5)P 2 inhibition of the synaptic vesicle protein casein kinase I which phosphorylates several proteins including SV2 (21) . Also, PI(4,5)P 2 is required for the ATP-dependent priming step preceding exocytosis (22) (23) (24) (25) . The role of PI(4,5)P 2 in the endocytotic pathway is critical and equally complicated. For example, PI(4,5)P 2 is required during early and late stages of clathrin-mediated endocytosis (26) . Furthermore, PI(4,5)P 2 interacts with proteins of the endocytotic machinery including AP2, epsin and AP180. These interactions are crucial for CCP formation (12) (13) (14) 32) . Binding of PI(4,5)P 2 to dynamin (27, 28) , which is recruited to the neck of the invaginating clathrin-coated vesicle, enables vesicle closure by endophilin I (29).
Activity of synaptojanin, a PI5-phosphatase that dephosphorylates PI(4,5)P 2 to PI(4)P (30) , is important for uncoating of endocytic vesicles (31) . These observations provide a compelling model of PI(4,5)P 2 in the regulation of CCP dependent endocytosis.
Neuronal internalization of BoNT/A involves CCP mediated endocytosis (33, 34, 35) . That is, disruption of CCP by incubating cells with potassium depleted buffer followed by hypotonic shock inhibits BoNT/A uptake into Neuro 2a cells (35, 36) . Thus, it is of importance to test whether disruption of CCP by depletion of membrane bound PI(4,5)P 2 reduces the uptake of BoNT/A. Here, we report that the mouse NMJ expresses the capsaicin receptor TRPV1. In vivo and in vitro activation of TRPV1 inhibited
BoNT/A uptake into motor nerve endings. Furthermore, we report that wortmannin (WMN) inhibits the effects of BoNT/A in vivo. Our data suggest that capsaicin inhibits BoNT/A uptake by depleting PI(4,5)P 2 and disrupting CCP mediated endocytosis. The net effect is capsaicin-induced protection of the NMJ from the inhibitory affects of BoNT/A.
METHODS

Animals
Adult Swiss Webster mice were anesthetized with ketamine (100 mg/kg) and xylazine (9 mg/kg) mixture 
Disruption of CCP
CCPs were disrupted as described previously (35) .
Immunoblotting
Cultured cells or diaphragm muscles dissected from anesthetized mice were flash frozen in liquid nitrogen and homogenized in phosphate buffered saline (PBS) containing 1% NP-40 and complete protease inhibitor cocktail (Amersham, USA). After centrifuging the homogenate in the cold at 14,000 rpm for 10 min, the lysate (40 µg) was resolved via SDS-PAGE after boiling in 1X Laemmli buffer. Immunoblotting was performed with anti-TRPV1 antibody (Santa Cruz Biotechnology, Inc., USA).
Immunohistochemistry
Preparations were fixed with 4% paraformaldehyde, permeabilized with 1% Triton, blocked with 2%
BSA, incubated with TRPV1 antibody in PBS (1:200) followed by FITC labeled secondary antibody
(1:5000), washed with PBS, mounted with vectashield on a glass slide and imaged. All treatments after fixing were performed at 4 ºC.
Two electrode voltage clamping
Triangularis sterni nerve-muscle preparations (TS; 37) were dissected from isoflurane anesthetized adult acquisition. Collected data were analyzed with pCLAMP 9.0 software.
Confocal microscopy
TS nerve-muscle preparations were bathed in 667 pM Alexa 647 labeled BoNT/A. Nerve stimulation (1 Hz) or addition of 40 mM KCl (NaCl reduced to 100 mM to maintain osmolarity) to the BoNT/Acontaining HRS initiated toxin uptake. After 90 min, preparations were fixed and exposed to Alexa 488 α-Bungarotoxin (α-BTX; 1 ng/ml, 6 hrs at 4°C) to label endplate acetylcholine receptors. The endplate region of the muscle was cut out, mounted on a slide with vectashield and observed with a NIKON LSM-410 confocal microscope equipped with argon and HeNe lasers at the Confocal Imaging Facility of the New Jersey Medical School.
Muscle strength assessment
Mice were adapted for 1 week to 300 sec episodes on a rotating (15 rpm) rod (Rotamex-5, Columbus
Instruments, Inc., USA) prior to study. To evaluate motor strength and coordination after BoNT/A injected alone or in combination with capsaicin, duration on the rotarod was tested biweekly. Mean duration on the rotarod was averaged for 3 runs 30 min apart. The in vivo muscle strength of legs and waist was assessed and scored using criteria of table 1.
Electromyography (EMG)
Animals anesthetized with KXM intraperitoneally were taped prone to a polystyrene foam board. A heated water pad maintained body temperature between 32 and 38° C. Stimulating electrodes (0.7 mm needles) were insulated with polytef (Dantec sensory needle, Skorlunde, Denmark); cathode was placed close to the sciatic nerve and the anode was placed subcutaneously 1 cm proximally. Motor responses were recorded with a ring electrode placed distal to the site of BoNT/A injection. The reference ring electrode was placed 1.2 cm distal to the recording electrode. Ground electrode was placed in the contralateral limb. Stimuli delivered through a stimulator were recorded by Dantec amplifiers connected to a computer. Filter settings were 500 Hz/5KHz. Stimulus intensity was increased until the compound muscle action potential (CMAP) was maximized. CMAP amplitude was recorded for both hind limbs.
Chemicals and drugs
BoNT/A and Alexa 647 BoNT/A were from Metabiologics Inc (WI, USA) and BB Tech (MA, USA), respectively. Wortmannin was from Calbiochem, USA. Other chemicals and drugs were from Sigma (USA).
Data analyses
Data were expressed as mean ± S.E.M. Student's t test evaluated the statistical significance for differences of population means; ** and *** indicate p < 0.001 and < 0.0001, respectively.
RESULTS
The right hind limb of the mouse in Figure were challenged with a rotating rod. All non-treated mice walked on the rod for at least 300 sec. Walk time significantly declined at 24 hrs and reached a minimal value of 127±48 sec at 4 days after BoNT/A.
Walk time recovered to 300 sec at 20 days after BoNT/A alone. In contrast, walk time did not decline when BoNT/A was injected at 4 hrs after capsaicin (Figure 1 B) . Furthermore, scoring for motor strength, by a blinded investigator using the criteria of table 1, suggested that capsaicin protected against the weakness caused by BoNT/A. That is, motor strength score was significantly less than control at 2 and 3 weeks after BoNT/A alone. In contrast, capsaicin pre-injected mice retained a normal score (Figure 1 C) .
Protection of muscle function may explain the larger weight of capsaicin pretreated versus BoNT/A alone treated mice (Figure 1 D) .
The preceding effects of capsaicin were associated with partial protection of neuromuscular physiology in vivo. Although CMAP amplitude declined for BoNT/A alone as well as BoNT/A after capsaicin groups of mice, the magnitude of the decline was significantly less for the latter group. That is, CMAP amplitude was 11.3 ± 2.3 (n=4), 0.7 ± 0.28 (n=4) and 4.6 ± 0.92 (n=4) mV at 4 weeks after BoNT/A for control, BoNT/A alone and capsaicin pre-injected mice, respectively. At 8 weeks after
BoNT/A, CMAP amplitude had partially recovered for the BoNT/A alone and capsaicin pre-injected groups to 2.6 ± 0.79 (n=4) and 6.7 ± 1.24 (n=4) mV, respectively. The force generating capacity was tested for EDL preparations isolated from mice injected with BoNT/A alone or after capsaicin. As anticipated, the nerve-evoked muscle twitch tension was reduced at
BoNT/A (Figure 3 A) ; tension was 140 ± 60.0 (n=4) and 500 ± 100 (n=4) mg for mice injected with
BoNT/A alone and at 4 hrs after capsaicin, respectively. Thus, while BoNT/A continued to significantly reduce twitch tension after capsaicin, the reduction was significantly less than after BoNT/A alone (Figure 3 B) . Capsaicin injected alone had no effect on force generation (Figure 3 C) .
Since capsaicin is an agonist of the TRPV1 receptor, we assayed whole muscle for this protein.
Immunoblots ( When applied alone WMN and capsaicin reduced the quantal content of EPCs (Figures 8 and 9 ).
Effects of capsaicin pretreatment
In vivo skeletal muscle performance was evaluated with performance on a rotating rod, hind limb strength evaluation, the TSR and electromyography. Also, when the mouse NMJ was exposed to capsaicin at a concentration of 100 µM, it decreased EPC amplitude in 2 hours. In contrast, injection of capsaicin alone did not affect muscle function and performance. Thus, it appears that the in vitro tissue effects of BoNT/A which persist after capsaicin pretreatment are not sufficient to inhibit muscle performance. This suggests participation of in vivo compensatory mechanisms.
Disruption of CCPs, a plausible mechanism for reduced BoNT/A uptake
Recent studies (33, 35) 
